Pennsylvania Recommended Titer Tests for Measles Immunity

As cases rise in Pennsylvania, officials suggest blood tests to confirm your immunity to the measles virus.

Updated on Sept. 23, 2026 in Allergies

Bold flat-color editorial illustration of a single medical vial, representing the clinical process of verifying measles antibody immunity.
The Pennsylvania Department of Health is recommending that residents undergo measles antibody titer tests to verify their immunity status amid a rise in local cases. AI Illustration. Upload story photo >

Live Poll

Would you get a blood test to confirm your measles immunity if you were uncertain?

The Pennsylvania Department of Health is urging residents to use titer tests to verify the presence of measles antibodies. This move follows an increase in measles cases across the state, highlighting the importance of confirming immunity for people of all ages and those with underlying health conditions.

Why it matters

With measles showing a 90-percent transmission rate among those without protection, confirming immunity is a critical step in preventing community spread. The rise in Pennsylvania cases makes understanding your individual immunity status more relevant for local public health.

Official health guidance centers on the use of titer tests, which identify antibody levels in the bloodstream. While the measles vaccine has been available since 1967, the current state recommendation relies on these blood draws to address rising local transmission.

The players

Pennsylvania Department of Health

The state agency responsible for managing public health surveillance and disease prevention across Pennsylvania.

The details

A titer test requires a simple blood draw to measure the concentration of specific antibodies circulating in your bloodstream. If the test shows sufficient antibody levels, it indicates that the immune system has successfully recognized the measles virus and possesses the memory to fight it. This provides a clear objective measure of immunity for individuals who may be uncertain about their vaccination history.

Timeline

  1. The measles vaccine was first developed in 1967.

  2. The Pennsylvania Department of Health began promoting titer testing in September 2026.

Health Landscape

Since the 1967 development of the measles vaccine, public health strategy has shifted from widespread routine vaccination to managing breakthrough risks in specific regions. This new guidance reflects an effort to tighten immunity gaps within the community.

If you are unsure of your vaccination status, it is worth discussing the benefits of a titer test with your primary care provider. This is particularly important for individuals with preexisting health conditions who may be at a higher risk of complications if exposed to measles.

The takeaway

Understanding your immunity status is a proactive way to mitigate risk during an active outbreak. If you have questions about your protection against measles, schedule a conversation with your physician to discuss whether a titer test is appropriate for you.

Further reading

For more on managing immunity and immune-related concerns, visit Allergies.

Source note: This article includes information reported by WJAC.

Live Poll

Would you get a blood test to confirm your measles immunity if you were uncertain?